SCHEMBL7378863

SCHEMBL7378863

CC1(C)C(=O)NN=C1c1ccc(N2CCC3(CC2)OCCO3)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 9/20 0.50
▸ PDE3B Q13370 8/20 0.50
▸ LGMN Q99538 1/20 0.43
▸ F12 P00748 1/20 0.37
▸ PDE4B Q07343 1/20 0.36
▸ DGAT1 O75907 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MGAT2 Q10469 1/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16149750 0.86 PDE3A (0.55) PDE3APDE3BPDE4BDGAT1ALDH1A1
SCHEMBL10668904 0.74 PDE3B (0.49) PDE3APDE3BPDE4BMAPTSMN1; SMN2
SCHEMBL10667501 0.73 PDE3B (0.74) PDE3APDE3BPDE4BALDH1A1MAPT
SCHEMBL6074497 0.70 LGMN (0.47) LGMNF12ALDH1A1MAPTCYP2C9
SCHEMBL14117662 0.69 LGMN (0.54) LGMNALDH1A1MAPTSMN1; SMN2HPGD
SCHEMBL2847376 0.68 PDE3A (0.55) PDE3APDE3BPDE4B
SCHEMBL6132758 0.68 LGMN (0.52) LGMNALDH1A1USP2HSD17B10KDM4E
SCHEMBL30817316 0.68 LGMN (0.47) LGMNF12RORCALDH1A1MAPT
SCHEMBL7380645 0.67 PDE3A (0.54) PDE3APDE3BPDE4BALDH1A1SMN1; SMN2
SCHEMBL6074502 0.67 MAPT (0.54) LGMNF12ALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4661496-A Cardiotonic and antihypertensive 2,4-dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY (US) 1987-04-28 — — US claimed
EP-0126651-A2 2,4-Dihydro-5-((substituted)phenyl)-4,4-disubstituted-3H-pyrazol-3-ones, 2,4-dihydro-5-((substituted)phenyl)-4, 4-disubstituted-3H-pyrazol-3-thiones, and a process for producing the same WARNER-LAMBERT COMPANY (US) 1984-11-28 — — EP claimed
US-4661496-A Cardiotonic and antihypertensive 2,4-dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY (US) 1987-04-28 — — US disclosed
US-4550119-A 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY (US) 1985-10-29 — — US disclosed
US-4526982-A 2,4-Dihydro-5-[(substituted)phenyl]-4,4-disubstituted-3H-pyrazol-3-ones WARNER-LAMBERT COMPANY, A CORP. OF DEL. 1985-07-02 — — US disclosed
EP-0126651-A2 2,4-Dihydro-5-((substituted)phenyl)-4,4-disubstituted-3H-pyrazol-3-ones, 2,4-dihydro-5-((substituted)phenyl)-4, 4-disubstituted-3H-pyrazol-3-thiones, and a process for producing the same WARNER-LAMBERT COMPANY (US) 1984-11-28 — — EP disclosed
Send feedback